Participants 73 131 6
overweight and obese subjects with cardiovascular disease.
Participants 133 407 6
BACKGROUND/OBJECTIVES The Sibutramine Cardiovascular OUTcomes (SCOUT) trial showed a significantly increased relative risk of nonfatal cardiovascular events, but not mortality, in overweight and obese subjects receiving long-term sibutramine treatment with diet and exercise
Participants 603 788 7
SUBJECTS/METHODS A total of 9804 male and female subjects, aged 55 years or older, with a body mass index of 27-45 kg m(-2) were included in this current subanalysis of the SCOUT tr
Participants 789 1002 3
al. Subjects were required to have a history of cardiovascular disease and/or type 2 diabetes mellitus with at least one cardiovascular risk factor (hypertension, dyslipidemia, current smoking or diabetic nephropa
Participants 2224 2273 4
 be harmful in this obese elderly cardiovascular 
